Syndax Pharmaceuticals (SNDX) Operating Leases (2019 - 2025)
Syndax Pharmaceuticals' (SNDX) quarterly Operating Leases came in at $1.5 million in Q4 2025, down 3.61% year-on-year from $1.6 million in Q4 2024, and down 3.61% quarter-over-quarter from $1.6 million in Q4 2024.
Syndax Pharmaceuticals (SNDX) Operating Leases (2019 - 2025) Analysis & Trends
Syndax Pharmaceuticals' Operating Leases history runs 7 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- On a quarterly basis, Operating Leases fell 3.61% year-over-year to $1.5 million in Q4 2025; TTM through Dec 2025 was $1.5 million, a 3.61% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 3.61% from the prior year.
- Operating Leases fell to $1.5 million in Q4 2025 per SNDX's latest filing, from $1.6 million in the prior quarter.
- Across five years, Operating Leases topped out at $1.6 million in Q4 2024 and bottomed at $22000.0 in Q2 2021.
- The 5-year median for Operating Leases is $676000.0 (2022), against an average of $685750.0.
- Across the five-year window, Operating Leases slumped 90.83% in 2021 and soared 2490.91% in 2022, its largest moves.
- Year by year, Operating Leases stood at $711000.0 in 2021, then slipped by 0.28% to $709000.0 in 2022, then slipped by 18.48% to $578000.0 in 2023, then surged by 173.01% to $1.6 million in 2024, then slipped by 3.61% to $1.5 million in 2025.
- Per Business Quant, the three latest SNDX Operating Leases figures stand at $1.5 million (Q4 2025), $1.6 million (Q4 2024), and $133000.0 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Jun 30, 2024 | 133,000.00 |
| Mar 31, 2024 | 327,000.00 |
| Dec 31, 2023 | 578,000.00 |
| Sep 30, 2023 | 851,000.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 588,000.00 |
| Dec 31, 2022 | 709,000.00 |
| Sep 30, 2022 | 768,000.00 |
| Jun 30, 2022 | 570,000.00 |
| Mar 31, 2022 | 643,000.00 |
| Dec 31, 2021 | 711,000.00 |
| Sep 30, 2021 | 798,000.00 |
| Jun 30, 2021 | 22,000.00 |
| Mar 31, 2021 | 60,000.00 |
| Dec 31, 2020 | 101,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 240,000.00 |
| Mar 31, 2020 | 306,000.00 |